Results 171 to 180 of about 260,154 (263)

Long Road to Identifying Peritoneal Mesothelioma: An Elusive Diagnosis. [PDF]

Cureus
Konduru TS, Gourisaria G, Ozen G, Karunakaran Thozhuthumparambil P.   +3 more
europepmc   +1 more source

Comparison of the Efficacy of First-Line Pemetrexed-Platinum and Gemcitabine-Platinum Regimens in Malignant Peritoneal Mesothelioma. [PDF]

Clin Med Insights Oncol
Bayram D, Efil SC, Türk S, Kara O, Sekmek S, Yücel Ş, Aktürk Esen S, Uçar G, Bal O, Algin E, Uncu D.   +10 more
europepmc   +1 more source

Malignant peritoneal mesothelioma: a review.

Annals of Translational Medicine, 2017
Joseph J Kim, S. Bhagwandin, D. Labow
semanticscholar   +1 more source

Malignant peritoneal mesothelioma as a secondary cancer following radiotherapy for cervical cancer: a case report and literature review. [PDF]

Gynecol Oncol Rep
Otsubo M, Aichi M, Kawashima Y, Yamanaka S, Imai Y, Miyagi E, Mizushima T.   +6 more
europepmc   +1 more source

A rare presentation of peritoneal mesothelioma: Esophageal encasement and Sister Mary Joseph nodule. [PDF]

Radiol Case Rep
Loong DWP, Smith R, Rattan R.
europepmc   +1 more source

Development and validation of a prognostic nomogram for patients with malignant peritoneal mesothelioma. [PDF]

Front Oncol
Wang X, Liu R, Wang C, Sun J, Yang D.
europepmc   +1 more source

Analysis on the efficacy and safety of chemotherapy combined with or without bevacizumab after CRS+HIPEC in patients with malignant peritoneal mesothelioma: a single-center retrospective study. [PDF]

Front Oncol
Yang ZR, Liang XL, Li XB, Zhang XJ, Wu HL, Su YD, Li Y, An SL.   +7 more
europepmc   +1 more source

Long-term survival in peritoneal mesothelioma treated with 24 consecutive PIPACs. [PDF]

Pleura Peritoneum
Mehdorn M, Jansen-Winkeln B, Rhode P, Niebisch S, Moulla Y, Schönherr T, Plum PS, Lordick F, Thieme R, Stocker G, von Laffert M, Gockel I, Stelzner S.   +12 more
europepmc   +1 more source

Dynamic evolution of NK cells and immune remodeling mediated by CRS + HIPEC: prognostic mechanisms and therapeutic implications for malignant peritoneal mesothelioma. [PDF]

World J Surg Oncol
Liu YT, Zhao QD, Liang XL, Ma R, Su YD, Yang R, Wei T, Wu HL, Fu YB, Cui YR, Yu Y, Li B, Li Y.   +12 more
europepmc   +1 more source

Fluorescence in situ hybridization (FISH) provides estimates of minute and interstitial BAP1, CDKN2A, and NF2 gene deletions in peritoneal mesothelioma

Modern Pathology, 2019
S. Brich, F. Bozzi, F. Perrone, E. Tamborini, A. Cabras, M. Deraco, S. Stacchiotti, G. Dagrada, S. Pilotti   +8 more
semanticscholar   +1 more source